chronic bowel disorder Flashcards
coeliac disease management
autoimmune disease that causes an immune response in intestinal mucosa
associated with gluten, wheat, barley, rye
can cause malabsorption of nutrients
management:
symptoms - abdominal pain, bloating,
malnutrition - give vit D, calcium etc.
- gluten free diet to avoid complications such as osteoporosis, malnutrition, cancer
diverticular disease and diverticulitis
conditions that affect large intestine, bowel - cause abdominal pain
- caused by small pouches in wall of intestine called diverticula
diverticulosis - small pouches but asymptomatic
diverticular disease - small pouches and symptomatic - constipation, diarrhoea, abdominal pain, rectal bleed
treat with fibre, bulk forming laxatives, paracetamol, anti-spasmodics if needed
diverticulitis - when pouches become inflamed/infected
complicated diverticulitis - abscess, fistula, perforation, obstruction, sepsis, haemorrhage
crohn’s disease management
CD - affects whole GIT, associated with thickened walls extending through all layers + deep ulceration
complications:
intestinal stricture or fistulae
anaemia and malnutrition
colorectal or small bowel cancer
acute:
1 flare up in 12 month period
- pred, methylpred or IV hydrocortisone
- if distal ileal or right sided - budesonide can be used if others dont work
aminosalicylates can be used - less S.E but less effective
2+ flares within 12 month period
- add on azathioprine/mercaptopurine
- methotrexate if aza/merc c/i
- severe: monoclonal antibodies
maintenance:
- smoking cessation
- monotherapy with azathioprine/mercaptopurine
- methotrextate
after surgery: azathioprine + metronidazole
when diarrhoea associated:
loperamide, codeine, colestyramine
- can use loperamide + codeine in CD not UC
fistulating CD:
- when fistula develops b/w intestine and perianal skin, bladder or vagina
- for symptoms - not fully heal - metronidazole +/- ciprofloxacin
- metro usually given for 1 month (no more than 3 months due to peripheral neuropathy)
- maintenance with azathioprine/mercaptopurine (infliximab if not responding)
- treatment must last at least 1 year
UC
UC - can affect rectum to whole of colon
- associated with bloody diarrhoea, defeaecation urgency, abdominal pain
- most common in 15-25 year olds
- complications such as colorectal cancer, secondary osteoporosis, VTE, toxic megacolon
types:
proctitis
proctosigmoiditis
distal/left sided
extensive colitis
pancolitis
UC follows a continuous pattern, whereas CD is patchy
UC acute treatment (mild to moderate)
proctitis - distal - topical preparations
extensive - systemic needed
diarrhoea - avoid loperamide + codeine - can cause toxic megacolon
proctitis:
1 - topical aminosalicylate
2- if no improvement in 4 weeks - add oral aminosalicylate
3 - still no improvement - topical or oral corticosteroids for 4-8 weeks
Pt can use oral aminosalicylate as 1st line if preferred (less effective)
proctosigmoiditis/left sided UC:
1 - topical aminosalicylate
2 - add high dose oral aminosalicylate if no improvement in 4 weeks OR high dose oral aminosalicyate + topical corticosteroids for 4-8 weeks
3 - stop topical - high dose oral aminosalicylate + oral corticosteroid for 4-8 weeks
extensive colitis:
1 - topical aminosalicyate + high dose oral aminosalicylate
2 - if no improvement in 4 weeks - stop topical - high dose oral amino + oral corticosteroid for 4-8 weeks
severe:
life-threatening, medical emergency
- IV hydrocortisone or methylpred - assess need for surgery
- if steroids c/i - IV ciclosporin, Infliximab
UC maintenance treatment
oral aminosalicylate recommended
- corticosteroid not suitable due to s.e
proctitis/proctosigmoiditis - topical +/- oral aminosal
left sided/extensive - low dose oral aminosal
2+ flare ups in 12 month period
- oral azathioprine or mercaptopurine
- monoclonal antibodies if no effect
imp points for aminosalicylates
sulfasalazine, mesalazine, olsalazine, balsalazide
nephrotoxic - monitor at initiation, at 3 months, then annually
hepatotoxic - monthly for first 3 months
blood disorders - monthly for first 3 months
c/i in salicylate hypersensitivity
sulfasalazine stains contact lenses orangey-yellow